25 Recruiting Plasma Cell Myeloma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Plasma Cell Myeloma
Top Recruiting Plasma Cell Myeloma Studies
Belantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients With Minimal Residual Disease Positive After Stem Cell Transplant
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
📍 UCLA Site Number : 8400010 — Los Angeles, California
View Study & Checklist ➔Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
View Study & Checklist ➔Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With High-Risk Multiple Myeloma
📍 Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔Lenalidomide Maintenance in Plasma Cell Myeloma
📍 Memorial Sloan Kettering Cancer Center — Basking Ridge, New Jersey
View Study & Checklist ➔Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
📍 Investigational Site Number: 8400006 — Fort Myers, Florida
View Study & Checklist ➔Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
View Study & Checklist ➔Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
📍 Emory University/Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
View Study & Checklist ➔Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
View Study & Checklist ➔